ANTI-TUMORAL EFFECT OF 5-FLUOROURACIL AND OXALIPLATIN IN A LIVER REGENERATION MODEL

被引：0
作者：
Sukia, I. Novo [1 ]
Bravo, M. Mendia [2 ]
Rodriguez, E. Gil [3 ]
Garcia-Alonso, I [4 ]
Montesinos, I. Ruiz [5 ]
de la Parte, B. Herrero [4 ]
机构：
[1] Hosp Zumarraga, Serv Cirugia Gen, Zumarraga, Spain
[2] Hosp Univ Donostia, Serv Cirugia Vasc, Donostia San Sebastian, Spain
[3] Hosp Univ Donostia, Serv Anal Clin, Donostia San Sebastian, Spain
[4] Univ Basque Country, Dept Cirugia & Radiol & Med Fis, Fac Med & Enfermeria, Bilbao, Spain
[5] Hosp Univ Donostia, Serv Cirugia Gen, Donostia San Sebastian, Spain
来源：
BRITISH JOURNAL OF SURGERY | 2023年 / 110卷
关键词：
D O I：
10.1093/bjs/znac443.026
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
znac443.02
引用
收藏
页数：1
相关论文
共 50 条
  • [31] NEOADJUVANT BEVACIZUMAB, OXALIPLATIN, 5-FLUOROURACIL, AND RADIATION FOR RECTAL CANCER
    Dipetrillo, Tom
    Pricolo, Victor
    Lagares-Garcia, Jorge
    Vrees, Matt
    Klipfel, Adam
    Cataldo, Tom
    Sikov, William
    McNulty, Brendan
    Shipley, Joshua
    Anderson, Elliot
    Khurshid, Humera
    Oconnor, Brigid
    Oldenburg, Nicklas B. E.
    Radie-Keane, Kathy
    Husain, Syed
    Safran, Howard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 124 - 129
  • [32] Oxaliplatin combined with 5-fluorouracil and methotrexate in advanced colorectal cancer
    Zampino, MG
    Lorizzo, K
    Rocca, A
    Locatelli, M
    Zorzino, L
    Manzoni, S
    Mazzetta, C
    Fazio, N
    Biffi, R
    De Braud, F
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2425 - 2428
  • [33] Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil
    deBraud, F
    Munzone, E
    Nole, F
    De Pas, T
    Biffi, R
    Brienza, S
    Aapro, MS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (03): : 279 - 283
  • [34] Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences
    M. Boisdron-Celle
    M. Craipeau
    S. Brienza
    R. Delva
    V. Guérin-Meyer
    E. Cvitkovic
    E. Gamelin
    Cancer Chemotherapy and Pharmacology, 2002, 49 : 235 - 243
  • [35] Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences
    Boisdron-Celle, M
    Craipeau, MC
    Brienza, S
    Delva, R
    Guérin-Meyer, V
    Cvitkovic, E
    Gamelin, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (03) : 235 - 243
  • [36] Stability of calcium levofolinate, 5-fluorouracil and oxaliplatin (FOLFOX) mixture
    Al Sabbagh, Chantal
    Agapova, Elena
    Boudy, Vincent
    Mignet, Nathalie
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (06) : 1303 - 1314
  • [37] Optimization of the anti-tumoral effect of fisetine along with cyclophosphamide in mice
    Touil, Y. S.
    Fellous, A.
    Seguin, J.
    Scherman, D.
    Chabot, G. G.
    BULLETIN DU CANCER, 2008, 95 (06) : 604 - 605
  • [38] Mutational Pattern Induced by 5-Fluorouracil and Oxaliplatin in the Gut Microbiome
    Wan, Li
    Li, Hexin
    Sun, Gaoyuan
    Zhang, Lili
    Xu, Hongtao
    Su, Fei
    He, Shunmin
    Xiao, Fei
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [39] Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients
    Alliot, C
    ANNALS OF ONCOLOGY, 2004, 15 (10) : 1576 - 1577
  • [40] THE EFFECT OF 5-FLUOROURACIL ON ERYTHROPOIESIS
    RICH, IN
    BLOOD, 1991, 77 (06) : 1164 - 1170
12345